Tweet President Trump announced on July 5 that he is planning to release an Executive Order that would enact a “most favored nation” requirement for prescription drug manufacturers. It was not immediately clear how this Executive Order would differ from the International Pricing Index proposal for Medicare that is currently under review with the Office [...] Read More
Louisiana took a precedent-setting step last week to confront the costly public health challenges associated with the Hepatitis C virus, (HCV) at the same time embarking on a plan to eventually rid the state of HCV. Health policy experts nationwide are watching the innovative program, anticipating that it could provide a model for states nationwide. [...] Read More
At today’s meeting, the Medicare Payment Advisory Commission (MedPAC) began their consideration of challenges facing the Medicare Part D prescription drug benefit, building up to a slate of recommendations to be included in their report to Congress later this year. Last year, the Commission approved several changes aimed at shifting more risk away from the […]
Read More